News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Overland ADCT Biopharma's ZYNLONTA® Receives Priority Review From NMPA for Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
Tuesday, July 25, 2023Overland ADCT BioPharma has made a significant announcement regarding their drug ZYNLONTA loncastuximab tesirinelpyl in China The China National Medical Products Administration NMPA has accepted the Biologics License Application BLA for ZYNLONTA
Molecure's Flagship Program, OATD-01, Granted FDA Approval for Phase Ii Clinical Testing Launch
Tuesday, July 25, 2023Molecure SA a biotechnology company listed on the WSE has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND Application
Eagle Pharmaceuticals Commences Phase 2 Clinical Trial to Evaluate CAL02, a Novel First-in-class Anti-toxin Drug Candidate, for Severe Community-acquired Bacterial Pneumonia (SCABP) Treatment
Monday, July 24, 2023Eagle Pharmaceuticals Inc Nasdaq EGRX has commenced a Phase study for CAL a groundbreaking antivirulence agent in severe communityacquired bacterial pneumonia SCABP patients
Menarini Group's ORSERDU® (Elacestrant) Receives Positive CHMP Opinion for European Commission Approval in Locally Advanced or Metastatic Breast Cancer with ESR1 Activating Mutation
Saturday, July 22, 2023The Menarini Group a renowned international pharmaceutical and diagnostics company along with its subsidiary Stemline Therapeutics Inc has received a positive opinion from the Committee for Medicinal Products for Human Use CHMP of the European Medici...
CHMP Approves Evrysdi® for Infants Under Two Months with Spinal Muscular Atrophy
Saturday, July 22, 2023PTC Therapeutics Inc NASDAQ PTCT has received a positive opinion from the Committee for Medicinal Products for Human Use CHMP for the extension of the Evrysdi risdiplam marketing authorization in the European Union EU to include infants under two mon...
Renovorx and Imugene to Collaborate on Oncolytic Virus Therapy Delivery via Proprietary Trans-arterial Micro-perfusion (TAMP™) Platform
Friday, July 21, 2023RenovoRx Inc Nasdaq RNXT and Imugene Ltd ASX IMU have recently entered into a strategic research collaboration aimed at optimizing the delivery of Imugenes oncolytic virus therapy using RenovoRxs TAMP TransArterial MicroPerfusion therapy platform
Grifols Announces Positive Topline Results From Phase 4 Study of XEMBIFY® (Immune Globulin Subcutaneous Human-klhw) Evaluating Biweekly Dosing Option for Patients
Friday, July 21, 2023Grifols a leading producer of plasmaderived medicines has announced positive results from a phase trial NCT evaluating the use of XEMBIFY in patients with primary immunodeficiencies PIDs
Mindbio Therapeutics Initiates Pre-screening of Participants for Groundbreaking Phase 2 Trial: Evaluating Home-based Lsd-microdosing in Major Depressive Disorder Patients
Thursday, July 20, 2023MindBio Therapeutics Corp CSEMBIOFrankfurtWF has recently initiated the prescreening process for participants in Phase LSDMicrodosing clinical trials signifying a significant step forward for the company
NANOBIOTIX Commences Novel Phase 1/2 Study to Assess Radiotherapy-activated NBTXR3 Alongside Anti-PD-1 Therapy in Advanced Cancer Patients
Thursday, July 20, 2023Nanobiotix a latestage biotechnology company focused on advancing cancer treatments through physicsbased approaches has announced the initiation of a Phase study to evaluate their product NBTXR in combination with antiPDL immune checkpoint inhibitor...
QIAGEN expands its offerings of digital PCR kits and services for the biopharma industry
Wednesday, July 19, 2023QIAGEN a leading biotechnology company listed on NYSE and Frankfurt Prime Standard has recently expanded its digital PCR dPCR offerings for the biopharma industrys cell and gene therapy development
